Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.459 SEK | +2.00% | -3.27% | -12.24% |
Apr. 16 | Mendus AB Announces Board Changes | CI |
Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
Sales 2024 * | - | Sales 2025 * | 264M 24.35M | Capitalization | 462M 42.64M |
---|---|---|---|---|---|
Net income 2024 * | -130M -11.99M | Net income 2025 * | 132M 12.17M | EV / Sales 2024 * | - |
Net cash position 2024 * | 59.34M 5.47M | Net cash position 2025 * | 192M 17.69M | EV / Sales 2025 * | 1.02 x |
P/E ratio 2024 * |
-3.83
x | P/E ratio 2025 * |
3.67
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.12% |
Latest transcript on Mendus AB
1 day | +2.00% | ||
1 week | -3.27% | ||
Current month | +2.34% | ||
1 month | -13.40% | ||
3 months | -0.54% | ||
6 months | +1.89% | ||
Current year | -12.24% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 74 | 01-12-31 | |
Erik Manting
CEO | Chief Executive Officer | 53 | - |
Lotta Ferm
DFI | Director of Finance/CFO | 58 | 21-02-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 12-12-31 | |
Helén Tuvesson
BRD | Director/Board Member | 62 | 19-12-31 |
Hans Preusting
BRD | Director/Board Member | 62 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.459 | +2.00% | 1,540,010 |
24-05-08 | 0.45 | -2.07% | 587,240 |
24-05-07 | 0.4595 | +0.88% | 686,335 |
24-05-06 | 0.4555 | -4.00% | 1,081,372 |
24-05-03 | 0.4745 | +2.15% | 779,506 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 11:29 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.24% | 42.66M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- IMMU Stock